More PRNewswire
View Older Stories View Newer Stories-
Broadridge's Shareholder Disclosure Hub Migrates to AWS, Boosting Global Reach, Resilience and Security
-
EQT agrees to sale of shares in Galderma Group AG to L'Oréal S.A.
-
GC Biopharma Ships First Doses of World's First Recombinant Anthrax Vaccine, 'BARYTHRAX inj.'
-
UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder
-
JETOUR T2 Served as Official Vehicle for G20 South Africa 2025
-
HCMCT Manipal Hospitals Delhi, India performs lifesaving heart transplant on a 54-year-old woman
-
JETOUR T2 Served as Official Vehicle for G20 South Africa 2025
-
ResumeTemplates.com Survey: Hiring Managers Reveal the Most Important Hard and Soft Skills for 2026
-
Riyadh Air and IBM Partner to Launch World's First AI-Native Airline
-
AsymBio Commences Commercial Operations at Fengxian Base, Strengthening Global Biopharmaceutical CDMO Capabilities
-
Unveiled in Abu Dhabi: the Shell Helix Ultra "Lightning Red" - the engine oil chosen by Scuderia Ferrari, with an exclusive global launch on TUHU.
-
Binance Becomes First Crypto Exchange To Secure a Global License Under ADGM Framework, Setting a New Standard in Digital-Asset Regulation
-
CIMC Unveils New Global Brand Logo and Visual Identity System
-
CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting
-
Median PFS Trending Beyond One Year: Leads Biolabs' LBL-034 Showcases Breakthrough Clinical Data in Oral Presentation at the 2025 ASH Annual Meeting
-
IASO Bio Presents Updated Results for Equecabtagene Autoleucel in High-Risk Newly Diagnosed Multiple Myeloma Patients at 2025 ASH
-
HD Hyundai Signs MOU with Indian State Government to Establish New Shipyard
-
ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma
-
Hydron Energy Demonstrates Low-Cost Production of Xenon with Negative Carbon Footprint for Satellite Propulsion
-
Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others
-
Global Times: Mogao Caves' mural paintings meet modern technology
-
CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting
-
Global Times: Xi Jinping Thought on Economy guides long-term steady economic growth for China: Jin Sheping
-
Linux Foundation Research Releases New Report: "The State of Open Source Japan 2025: Accelerating Business Value through Strategic Open Source Engagement"
-
Linux Foundation Welcomes Mitsubishi Electric as Gold Member During Open Source Summit Japan
-
AI-for-Science Startup ChemLex Raises USD 45M, Launching Self-Driving Lab for Drug Discovery in Singapore
-
RESPIREE SECURES SINGAPORE HSA APPROVAL FOR ITS AI-ENABLED 1BIO™AI SOFTWARE TO SUPPORT ACUTE DETERIORATION DETECTION
-
ALLUONE Launches IoT-Based Home Smart Garden 'Watering Garden'
-
Matthews International Provides Update on Actions to Create Shareholder Value and Addresses Director Nominations
-
Anchorage Digital Integrates Middleware Provider BridgePort to Enhance Institutional Settlement Infrastructure
-
Lilly's Jaypirca (pirtobrutinib) met its primary endpoint in first-of-its-kind, head-to-head Phase 3 study versus Imbruvica (ibrutinib)
-
Replicor publishes data from its compassionate access program in HBV/HDV
-
Prologis announces redemption of 3.00% Notes due 2026
-
/C O R R E C T I O N -- China International Supply Chain Expo/
-
Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years
-
Lavnlux Introduces Porto, a Face-Shielding Shower Helmet Designed to Enhance At-Home Wellness
-
ADAM S. KUTNER, INJURY ATTORNEYS, CELEBRATES FOUR PRESTIGIOUS 2025 BEST OF LAS VEGAS GOLD AWARDS
-
PEARL HARBOR AVIATION MUSEUM LAUNCHES $51 MILLION "REMEMBER PEARL HARBOR" NATIONAL CAMPAIGN ON DECEMBER 7th TO RESTORE AMERICA'S WORLD WAR II AVIATION BATTLEFIELD
-
New Era Releases 2025 Major League Soccer Champions Collection Celebrating Inter Miami CF
-
The 4th China International Supply Chain Expo Set for Beijing in June 2026
-
Rigel Presents Updated Data from the Ongoing Phase 1b Study Evaluating R289 in Patients with Lower-Risk MDS at the 67th ASH Annual Meeting and Exposition
-
Orna Therapeutics Presents New Data Supporting its in vivo CAR Programs for Autoimmune Diseases and Oncology at the 67th American Society of Hematology Annual Meeting
-
Studies Point to a Growing Role for New Therapies and Immunotherapies in Treating Blood Cancers
-
HALLMARK PRESENTS A DISNEY LOVE STORY
-
Washable Area Rugs (2025): Rugs Direct Named Top Choice for Practical & Stylish Home Decor by Expert Consumers
-
Best Accounting Software for Self-Employed (2025): QuickBooks Named Top Choice for Freelancers and Entrepreneurs by Expert Consumers
-
CARsgen's CAR-T Product Zevor-Cel Included in China's Commercial Health Insurance Innovative Drug Catalogue
-
All Approved Indications of Five Akeso's Innovative Drugs Included in China's Latest NRDL: Featuring Two First-in-Class Bispecifics with New First-Line Indications and Three Newly Negotiated Drugs
-
Skymizerʼs HyperThought™ Wins "Best IP/Processor of the Yearˮ and "Most Promising Productˮ at EE Awards Asia 2025
-
Innovent Announces Inclusion of Seven Innovative Drugs including TYVYT New Indication and SYCUME in China's National Reimbursement Drug List
